Compass Therapeutics

CMPX

Market cap $777M

Overview Fund Trends Analyst Outlook Journalist POV

4.53 USD

--0.24

5.03%

At close Updated Oct 16, 2:01 PM EDT

1 day

-5.03%

5 days

11.3%

1 month

25.48%

3 months

44.73%

6 months

166.47%

Year to date

223.57%

1 year

128.79%

5 years

13.82%

10 years

13.82%

About: Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Employees: 35

Healthcare Biotechnology